Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279395 · ClinicalTrials.gov registry record
Anti-inflammatory Agents and Cholesterol Metabolism
A clinical trial, sponsored by Winthrop University Hospital.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01279395 is a clinical trial that was terminated before completion, run by Winthrop University Hospital. The registered enrollment target is 3 participants.
The verdict
NCT01279395 was terminated before completion, sponsored by Winthrop University Hospital.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
We hypothesize that administration of anti-inflammatory medications such as celecoxib, naprosyn and diclofenac will cause changes in the blood plasma and white blood cells of patients such that they will be less able to efficiently process cholesterol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-11 |
| Est. Completion | 2018-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279395
The ClinicalTrials.gov registry entry for NCT01279395 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01279395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01279395 about?
NCT01279395 is a clinical study titled "Anti-inflammatory Agents and Cholesterol Metabolism". We hypothesize that administration of anti-inflammatory medications such as celecoxib, naprosyn and diclofenac will cause changes in the blood plasma and white blood cells of patients such that they will be less able to efficiently process cholesterol.
What is the current status of trial NCT01279395?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2010-11. Estimated completion is 2018-01-18.
Who is sponsoring clinical trial NCT01279395?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.